SEC Form D · filed August 4, 2017
Amylyx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
null Platinum Group · Calabasas, CADirectorNolan Chicoine · Calgary, Alberta, CanadaDirectorDavid B. Carrig · Dallas, TXDirectorEric M. Siegal · CHICAGO, ILExecChristopher F. Linneman · Boston, MAExec · DirectorSriram N. Viswanathan · Grand Cayman, Cayman IslandsDirectorJames F. Kellogg Iii · Boston, MADirectorJonathan J. Desimone · Boston, MAExec · DirectorDaniel M. Rosenbloom · CHICAGO, ILExecMikhail Plam · Louisville, CODirectorDavid C. Barker · Louisville, COExec · DirectorNiles C. Utlaut · Louisville, COExec · DirectorCorporate Director Gpe Viii Investments Manager Limited · Nicosia, G4DirectorJohn F. Warnken-Brill · San Francisco, CADirectorDavid F. Flannery · San Francisco, CADirectorBasil Williams · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗